Description

Technical Parameters

Afoxolaner CAS 1093861-60-9 is an active ingredient used in veterinary medicine for the treatment and prevention of flea and tick infestations in dogs and cats. It belongs to the class of drugs known as isoxazolines.

Afoxolaner CAS 1093861-60-9

Product: Afoxolaner CAS 1093861-60-9

Alternative Name: NexGard; Afoxolaner; CAS 1093861-60-9; 1093861-60-9; Afoxolaner API;

Chemical Name: (R,E)-N-(2,3-dichloro-6-(3-chloro-5-(trifluoromethyl)-phenyl)-1,4-dihydro-1-oxo-2(2-thienyl)-5-pyrazinyl)-2-methyl-2-(4-(2,2,2-trifluoroethoxy)phenyl)acetamide

Molecular formula: C₂₆H₁₇ClF₉N₃O₃
Molecular mass: 625.87

CAS No.: 1093861-60-9

EINECS Number: 832-051-7

MDL Number: MFCD30533411

Afoxolaner Intermediates: 131986-05-5

Here are some potential benefits associated with Afoxolaner:

1. Flea Control: Afoxolaner is highly effective in controlling flea infestations on dogs and cats. It works by targeting the nervous system of fleas, leading to paralysis and death. Afoxolaner provides rapid and long-lasting flea control, helping to alleviate itching and discomfort in pets.

2. Tick Prevention: Afoxolaner is also effective against ticks, including species such as the American dog tick (Dermacentor variabilis) and the lone star tick (Amblyomma americanum). It kills ticks by interfering with their nervous system. Preventing tick infestations is crucial as ticks can transmit various diseases to pets, including Lyme disease, ehrlichiosis, and anaplasmosis.

3. Reduction of Flea and Tick-Borne Diseases: By effectively controlling fleas and ticks, Afoxolaner helps reduce the risk of flea and tick-borne diseases in pets. These diseases can cause a range of health issues, including skin irritations, anemia, allergic reactions, and the transmission of various pathogens.

1. Payment term

TT, LC

2. Delivery date

Negotiable

3. Market

Middle East / Africa / Asia / South America / Europe

4. Sample

Available
5. Executive standards
USP/EP

6. Qualification certificate

For research use only

7. Packaging size specification

Inner package: single-layer polyethylene bag and aluminum foil bag.

Outer package: fiber drum.

Packaging size: 25 kg/drum.

Our Advantage

We have branch offices in Dubai and India

we have own reliable & Long-term cooperative & experienced factory

Variety products for selection from China and India

We can customize according to your requirements

We can do OEM & ODM

We can offer N-1 to API

Afoxolaner CAS 1093861-60-9 API FAQ

Q: How does Afoxolaner work?

A: Afoxolaner works by targeting the nervous system of fleas and ticks, specifically by blocking certain receptors that are essential for their survival. This leads to paralysis and death of the parasites.

Q: What conditions is Afoxolaner used to treat?

A: Afoxolaner is used to treat and prevent flea and tick infestations in dogs and cats. It is effective against various species of fleas and ticks, including those that transmit diseases such as Lyme disease and Rocky Mountain spotted fever.

Q: How is Afoxolaner administered?

A: Afoxolaner is typically administered as an oral medication in the form of a chewable tablet or flavored treat for dogs, or as a topical spot-on treatment for both dogs and cats. The dosage and frequency of administration depend on the specific product and the weight of the animal.

Q: Is Afoxolaner safe for pets?

A: Afoxolaner is generally considered safe when used according to the manufacturer's instructions.

Q: Can Afoxolaner be used in puppies and kittens?

A: The use of Afoxolaner in puppies and kittens may vary depending on the product and the age or weight of the animal. Some Afoxolaner products are indicated for use in puppies and kittens as young as 8 weeks old.

Hot Tags: afoxolaner cas 1093861-60-9, China afoxolaner cas 1093861-60-9 manufacturers, suppliers, factory, intermediate azo compounds, api for human job performance data, intermediate acids, human api for sports analytics, human api for technology companies, intermediate compaction products